Skip to main content
×
Home

Duration of shedding of Verocytotoxin-producing Escherichia coli in children and risk of transmission in childcare facilities in England

  • G. DABKE (a1), A. LE MENACH (a2) (a3), A. BLACK (a1), J. GAMBLIN (a1), M. PALMER (a1), N. BOXALL (a2) and L. BOOTH (a1)...
Summary
SUMMARY

Exclusion of children with presumptive Verocytotoxin-producing Escherichia coli (VTEC) from childcare facilities until negative stool specimens are obtained is routine practice that disrupts families. We estimated the shedding and exclusion duration and transmission risk in such facilities. The study population comprised 225 children aged <6 years attending 201 childcare facilities in England with microbiologically confirmed VTEC in 2010–2011. We estimated the interval from onset to first negative specimen, and identified transmission events with secondary cases linked to facilities. The median duration of shedding was 31 days, and median period of exclusion was 39·5 days. Cases attending facilities while shedding VTEC did so for a median of 2 days before exclusion. Secondary cases occurred in 6/83 facilities (7%) attended by infectious cases. Despite evidence of VTEC shedding at facilities, transmission is relatively low. Revised control guidelines could consider supervised return for prolonged asymptomatic shedders.

Copyright
Corresponding author
* Author for correspondence: Dr L. Booth, Wessex PHEC, Unit 8 Fulcrum 2, Solent Way, Whiteley, Hampshire PO15 7FN, UK. (Email: linda.booth@phe.gov.uk)
References
Hide All
1. Health Protection Agency. Epidemiology of VTEC in England & Wales 2011. (http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/EscherichiaColiO157/EpidemiologicalData/). Accessed 28 March 2013.
2. Gould LH, et al. Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000–2006. Clinical Infectious Diseases 2009; 49: 14801485.
3. Tuttle J, et al. Lessons from a large outbreak of Escherichia coli O157:H7 infections: insights into the infectious dose and method of widespread contamination of hamburger patties. Epidemiology and Infection 1999; 122: 185192.
4. Pennington H. Escherichia coli O157. Lancet 2010; 376: 14281435.
5. Roberts JA, Upton PA, Azene G. Escherichia coli O157:H7; an economic assessment of an outbreak. Journal of Public Health Medicine 2000; 22: 99107.
6. Health Protection Agency. The VTEC operational manual 2011. Operational guidance for HPA staff dealing with cases and incidents of VTEC infection (http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1279889252950). Accessed 26 March 2013.
7. Health Protection Agency. HPZone update and award 2011. (http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317131631173). Accessed 26 March 2013.
8. Health Protection Agency. Verocytotoxin-producing Escherichia coli. Enhanced surveillance questionnaire 2012. (http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1229935272853). Accessed 28 March 2013.
9. Wells JG, et al. Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype. Journal of Clinical Microbiology 1983; 18: 512520.
10. Belongia EA, et al. Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities. Journal of the American Medical Association 1993; 269: 883888.
11. Wahl E, et al. Investigation of an Escherichia coli O145 outbreak in a child day-care centre – extensive sampling and characterization of eae- and stx1-positive E. coli yields epidemiological and socioeconomic insight. BMC Infectious Diseases 2011; 11: 238.
12. Miliwebsky E, et al. Prolonged fecal shedding of Shiga toxin-producing Escherichia coli among children attending day-care centers in Argentina. Revista Argentina de Microbiologia 2007; 39: 9092.
13. Shah S, et al. Prolonged fecal shedding of Escherichia coli O157:H7 during an outbreak at a day care center. Clinical Infectious Diseases 1996; 23: 835836.
14. Willshaw GA, et al. Verocytotoxin-producing Escherichia coli (VTEC) O157 and other VTEC from human infections in England and Wales: 1995–1998. Journal of Medical Microbiology 2001; 50: 135142.
15. Jenkins C, et al. Assessment of a real-time PCR for the detection and characterization of verocytotoxigenic Escherichia coli . Journal of Medical Microbiology 2012; 61: 10821085.
16. Health Protection Agency. Investigation of faecal specimens for bacterial pathogens. National Standard Method, BSOP 30, Issue 7, 2010.
17. Karch H, et al. Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli O157 in diarrheal diseases. Journal of Clinical Microbiology 1995; 33: 16021605.
18. Brown JA, et al. Outbreak of shiga toxin-producing Escherichia coli serotype O26: H11 infection at a child care center in Colorado. Pediatric Infectious Disease Journal 2012; 31: 384388.
19. Chapman PA, Wright DJ, Siddons CA. A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli O157 from bovine faeces. Journal of Medical Microbiology 1994; 40: 424427.
20. Boyce TG, Swerdlow DL, Griffin PM. Escherichia coli O157:H7 and the hemolytic-uremic syndrome. New England Journal of Medicine 1995; 333: 364368.
21. Pai CH, et al. Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study. Journal of Infectious Diseases 1988; 157: 10541057.
22. Wong CS, et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. New England Journal of Medicine 2000; 342: 19301936.
23. Pavia AT, et al. Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. Journal of Pediatrics 1990; 116: 544551.
24. Ikeda K, et al. Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompan ying Escherichia coli O157:H7 infection. Clinical Nephrology 1999; 52: 357362.
25. Proulx F, et al. Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. Journal of Pediatrics 1992; 121: 299303.
26. Safdar N, et al. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. Journal of the American Medical Association 2002; 288: 9961001.
27. Nitschke M, et al. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. Journal of the American Medical Association 2012; 307: 10461052.
28. Seifert ME, Tarr PI. Therapy: azithromycin and decolonization after HUS. Nature Reviews Nephrology 2012; 8: 317318.
29. Snedeker KG, et al. Primary and secondary cases in Escherichia coli O157 outbreaks: a statistical analysis. BMC Infectious Diseases 2009; 9: 144.
30. Parry SM, Salmon RL. Sporadic STEC O157 infection: secondary household transmission in Wales. Emerging Infectious Diseases 1998; 4: 657661.
31. Al-Jader L, et al. Outbreak of Escherichia coli O157 in a nursery: lessons for prevention. Archives of Disease in Childhood 1999; 81: 6063.
32. Lerman Y, et al. A cluster of cases of Escherichia coli O157 infection in a day-care center in a communal settlement (Kibbutz) in Israel. Journal of Clinical Microbiology 1992; 30: 520521.
33. Reida P, et al. An outbreak due to enterohaemorrhagic Escherichia coli O157:H7 in a children day care centre characterized by person-to-person transmission and environmental contamination. Zentralblatt fur Bakteriologie 1994; 281: 534543.
34. Gilbert M, et al. Screening policies for daycare attendees: lessons learned from an outbreak of E. coli O157:H7 in a daycare in Waterloo, Ontario. Canadian Journal of Public Health 2008; 99: 281285.
35. Tam CC, et al. Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut 2012; 61: 6977.
36. Vogelsang E, Pulz M. Environmental studies of asymptomatic kindergarten children as carriers of enterohemorrhagic Escherichia coli (EHEC) in the Ammerland district [in German]. Gesundheitswesen 1999; 61: 3844.
37. Swerdlow DL, Griffin PM. Duration of faecal shedding of Escherichia coli O157:H7 among children in day-care centres. Lancet 1997; 349: 745746.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 5
Total number of PDF views: 43 *
Loading metrics...

Abstract views

Total abstract views: 189 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 18th November 2017. This data will be updated every 24 hours.